Asthma drug helps with Multiple sclerosis treatment – Health Jackal


MedIndia

Asthma drug helps with Multiple sclerosis treatment
Health Jackal
The results of a new study show that by adding albuterol, a drug normally used to treat asthma and other respiratory diseases, to an existing treatment for
Health Minute: Asthma medication helpful for MS patientsExaminer.com
Asthma drug can help treat MSPress TV
Asthma Drug Can Prove Effective for MS PatientsTopNews United Kingdom (blog)
Stuff.co.nz –Oneindia –The Pharma Letter (subscription)
all 75 news articles »

View full post on asthma – Google News

Common Asthma Drug Could Speed MS Treatment – BusinessWeek

Common Asthma Drug Could Speed MS Treatment
BusinessWeek
13 (HealthDay News) — A common asthma drug might accelerate the benefits of treatment for multiple sclerosis when combined with standard medicine,
Asthma drug albuterol improves multiple sclerosis when added to conventional Los Angeles Times
Asthma drug may help multiple sclerosis: studyReuters
Asthma Drug May Help MS PatientsMedPage Today
EurekAlert (press release)
all 16 news articles »

View full post on asthma – Google News

Treatment for S. aureus skin infection works in mouse model

Scientists from the National Institutes of Health and University of Chicago have found a promising treatment method that in laboratory mice reduces the severity of skin and soft-tissue damage caused by USA300, the leading cause of community-associated Staphylococcus aureus infections in the United States. By neutralizing a key toxin associated with the bacteria, they found they could greatly reduce the damaging effects of the infection on skin and soft tissue. Community strains of S. aureus cause infection in otherwise healthy people and are considered extremely virulent, as opposed to hospital strains that infect people who already are weakened by illness or surgery.

View full post on National Institutes of Health (NIH) News Releases

Systemic lupus erythematosus: From mouse models to human disease and treatment

On Sept. 2-3, 2010, the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Cancer Institute (NCI), the National Institute of Allergy and Infectious Diseases (NIAID), and the NIH Office of Research on Women’s Health (ORWH) will convene a two-day conference on Systemic Lupus Erythematosus: From Mouse Models to Human Disease and Treatment. This meeting will bring together basic research scientists working on models of autoimmune disease relevant to systemic lupus erythematosus (SLE), with clinicians treating lupus patients. There are numerous mouse models of lupus, but their relevance to the actual disorder is still a subject for debate. Moreover, since SLE is a heterogeneous disease, some features of the disorder may be better reflected in one or another mouse model.

View full post on National Institutes of Health (NIH) News Releases